BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan Y, Wang K, Tang X, Gao JF, Wen BY. Phytochemicals protect L02 cells against hepatotoxicity induced by emodin via the Nrf2 signaling pathway. Toxicol Res (Camb) 2019;8:1028-34. [PMID: 32153769 DOI: 10.1039/c9tx00220k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Gao J, Shi N, Guo H, Gao J, Tang X, Yuan S, Qian J, Wen B. UPLC-Q-TOF/MS-Based Metabolomics Approach to Reveal the Hepatotoxicity of Emodin and Detoxification of Dihydromyricetin. ACS Omega 2021;6:5348-58. [PMID: 33681574 DOI: 10.1021/acsomega.0c05488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Sun Y, Liu S, Yang S, Chen C, Yang Y, Lin M, Liu C, Wang W, Zhou X, Ai Q, Wang W, Chen N. Mechanism of Dihydromyricetin on Inflammatory Diseases. Front Pharmacol 2022;12:794563. [DOI: 10.3389/fphar.2021.794563] [Reference Citation Analysis]
3 Zhang H, Caprioli G, Hussain H, Khoi Le NP, Farag MA, Xiao J. A multifaceted review on dihydromyricetin resources, extraction, bioavailability, biotransformation, bioactivities, and food applications with future perspectives to maximize its value. eFood 2021;2:164-84. [DOI: 10.53365/efood.k/143518] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen J, Wang X, Xia T, Bi Y, Liu B, Fu J, Zhu R. Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease. Biomed Pharmacother 2021;142:111927. [PMID: 34339914 DOI: 10.1016/j.biopha.2021.111927] [Reference Citation Analysis]